We are live on ! Find out more
ONXX

ONYX PHARMACEUTICALS INC
ONXX

Delisted

ONXX was delisted on the 30th of September, 2013.

Back to rankings

0 hedge funds and large institutions have $0 invested in ONYX PHARMACEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 257 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 258 → 0 (-258)

100% less funds holding in top 10

Funds holding in top 10: 46 → 0 (-46)

100% less capital invested

Capital invested by funds: $7.38B → $0 (-$7.38B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 257

Holders
–
Holders Change
-258
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-46
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
257
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$512M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$421M
3
DKCM
Davidson Kempner Capital Management
New York
-$393M
4
HI
HBK Investments
Texas
-$339M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$259M
Name Holding Trade Value Shares
Change 		Change in
Stake
Thrivent Financial for Lutherans
126
Thrivent Financial for Lutherans
Minnesota
– -$6.4M -51,304 Closed
DekaBank Deutsche Girozentrale
127
DekaBank Deutsche Girozentrale
Germany
– -$5.92M -47,441 Closed
LOM
128
Loeb Offshore Management
New York
– -$5.66M -45,373 Closed
PPA
129
Parametric Portfolio Associates
Washington
– -$5.27M -42,292 Closed
Axa
130
Axa
France
– -$5.08M -40,741 Closed
PG
131
PEAK6 Group
Illinois
– -$2.23M -35,772 Closed
BlackRock
132
BlackRock
New York
– -$4.34M -34,801 Closed
Canada Pension Plan Investment Board
133
Canada Pension Plan Investment Board
Ontario, Canada
– -$4.33M -34,700 Closed
FNYS
134
First New York Securities
New York
– -$4.29M -34,400 Closed
IRF
135
IBM Retirement Fund
New York
– -$4.23M -33,945 Closed
HSBC Holdings
136
HSBC Holdings
United Kingdom
– -$4.17M -33,430 Closed
VKH
137
Virtu KCG Holdings
New York
– -$4.12M -33,016 Closed
STIA
138
Stone Toro Investment Advisers
New Jersey
– -$4.12M -33,000 Closed
Ohio Public Employees Retirement System (OPERS)
139
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$4.01M -32,196 Closed
Macquarie Group
140
Macquarie Group
Australia
– -$3.99M -32,000 Closed
BIM
141
BlackRock Investment Management
Delaware
– -$3.9M -31,253 Closed
CAS
142
CTC Alternative Strategies
Illinois
– -$3.87M -31,000 Closed
APG Asset Management
143
APG Asset Management
Netherlands
– -$3.84M -30,834 Closed
GWM
144
Graybill Wealth Management
Illinois
– -$3.84M -30,803 Closed
JG
145
Jefferies Group
New York
– -$3.67M -29,428 Closed
ProShare Advisors
146
ProShare Advisors
Maryland
– -$3.48M -27,904 Closed
Allianz Asset Management
147
Allianz Asset Management
Germany
– -$3.47M -27,840 Closed
ACM
148
Ashford Capital Management
Delaware
– -$3.19M -25,550 Closed
SAM
149
Shell Asset Management
Netherlands
– -$2.96M -23,742 Closed
VAM
150
Visium Asset Management
New York
– -$2.95M -23,635 Closed
4 5
6
7 8

ONXX Hedge Fund Activity: Q4 2013 in Review

0 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ONYX PHARMACEUTICALS INC (ONXX) for Q4 2013, worth a combined $0 — down 100% from $7.38B a quarter earlier.

Sellers outnumbered buyers: 257 funds closed out of ONXX and 0 opened new positions — a net loss of 257 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Adage Capital Partners, exiting entirely with an estimated $512M sold.

  • 0 institutional investors held ONYX PHARMACEUTICALS INC (ONXX) as of Q4 2013, down from 258 in Q3 2013.
  • Funds reported $0 of ONYX PHARMACEUTICALS INC stock for Q4 2013, down 100% quarter-over-quarter.
  • 0 funds opened new ONYX PHARMACEUTICALS INC positions in Q4 2013 and 257 closed out, a net change of -257 holders.
  • The largest ONYX PHARMACEUTICALS INC seller in Q4 2013 was Adage Capital Partners, an estimated $512M sold.

Based on aggregated 13F filings for Q4 2013.